PFE Is Its Stock Price A Worthy Investment? Learn More

The company’s top seller in 2021 was Comirnaty, a COVID-19 vaccine. It generated nearly $37 billion in 2021 and was followed by Prevnar, Ibrance and Eliquis with just over $5 billion in sales each. Other blockbuster names on Pfizer’s list include Xeljanz and Enbrel, each bringing in $3.5 billion. Pfizer operates 39 research and production facilities worldwide and sells its products in 125 countries.

The “Quality” component of the POWR https://1investing.in/ focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks. With a price/earnings ratio of 7.33, PFIZER INC P/E ratio is greater than that of about merely 20.98% of stocks in our set with positive earnings. PFE has a market capitalization of $229,820,151, more than approximately 99.36% of US stocks. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed.

Their PFE share price forecasts range from $40.00 to $75.00. On average, they anticipate the company’s share price to reach $49.87 in the next year. This suggests a possible upside of 19.5% from the stock’s current price. View analysts price targets for PFE or view top-rated stocks among Wall Street analysts. 13 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Pfizer in the last twelve months. There are currently 8 hold ratings and 5 buy ratings for the stock.

RATIOS/PROFITABILITY

If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan’s own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself. World War I caused a shortage of materials for making citric acid and forced the company to seek alternatives. The one they latched on to was the fermentation of certain fungi known to produce citric acid naturally.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. We believe the Seagen acquisition is likely to bring in close to $8 billion of revenue by 2030. While Pfizer expects over $10 billion in Seagen-related sales by 2030, we are skeptical of that estimate and would need to see strong pipeline data before increasing our estimates to Pfizer’s guidance.

‘Very Upset’ Gavi Close To Joining Chelsea On Free Transfer After FC Barcelona Star’s Agent Meeting: Reports

Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.

Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price.

Is It Time to Sell PFE? Shares are up today.

MarketBeat has tracked 32 news articles for Pfizer this week, compared to 21 articles on an average week. The largest positive contribution comes from its “Physical diseases” impact, which is mostly driven by its “Covid-19 vaccines”, “Pneumococcal vaccines”, and “Apixaban” products. Based on earnings estimates, Pfizer will have a dividend payout ratio of 43.27% next year.

0.78% of the sterling overnight interbank average rate shares of Pfizer have been sold short. Any bold move to shrink the Bank of Japan’s balance sheet will upend global markets and send high-risk assets sharply lower in favor of more conventional and liquid ones. SHANGHAI – Pfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on Tuesday citing…

What Motivated Vyant Bio (VYNT) Stock To Climb 116%?

To see all exchange delays and terms of use, please see disclaimer. Over the past 49 months, PFE’s revenue has gone up $46,303,000,000.The table below shows PFE’s growth in key financial areas . Over the past 243 months, PFE’s price/sales ratio has gone down 3.8.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. In addition, the company is involved in the contract manufacturing business. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc.

Cheap high-quality stocks from the Morningstar Wide Moat Focus Index are attractive for long-term investors. Pfizer is paying close to $43 billion for Seagen, which is higher than our valuation for the latter company. However, we expect cost synergies (close to $1 billion highlighted by management) to help offset this overpayment. Further, if Seagen’s pipeline of early-and mid-stage drugs develops better than our expectations, we believe there could be upside for Pfizer. Be it growth or blue-chip stocks, a key success factor is to invest in undervalued names.

Pfizer (PFE)

Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. SectorIndustryMarket CapRevenue MedicalLarge Cap Pharmaceutical$234.243B$100.330B Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Its business comprises six business units – Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. The Consumer Healthcare segment, an over-the-counter medicines business, was merged with Glaxo’s unit to form a new joint venture.? The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

Banking stocks fell sharply amid contagion worries, with Wells Fargo… – The U.S. health regulator said on Thursday the current emergency use authorization for Pfizer’s COVID-19 antiviral pill for high-risk adolescents will continue to… There may be delays, omissions, or inaccuracies in the Information. The technique has proven to be very useful for finding positive surprises. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.

• It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
• Seattle-area biotech experts are eying the past with a wary eye in the wake of this week’s news that Pfizer plans to acquire Bothell, Wash.
• The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
• Over the past three years, the company’s dividend has grown by an average of 3.31% per year.
• Any bold move to shrink the Bank of Japan’s balance sheet will upend global markets and send high-risk assets sharply lower in favor of more conventional and liquid ones.

Data may be intentionally delayed pursuant to supplier requirements. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. In these tumultuous times, with markets facing substantial headwinds from yet another financial crisis, savvy investors are on the lookout for safe havens.